Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1991 4
1993 2
1994 3
1996 3
1997 1
1998 1
1999 3
2000 6
2001 8
2002 4
2003 7
2004 12
2005 14
2006 11
2007 8
2008 11
2009 19
2010 19
2011 28
2012 14
2013 20
2014 28
2015 27
2016 25
2017 10
2018 23
2019 21
2020 27
2021 49
2022 34
2023 29
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Results by year

Filters applied: . Clear all
Page 1
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B. Hadjadj J, et al. Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13. Science. 2020. PMID: 32661059 Free PMC article.
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial.
Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M. Magrin E, et al. Nat Med. 2022 Jan;28(1):81-88. doi: 10.1038/s41591-021-01650-w. Epub 2022 Jan 24. Nat Med. 2022. PMID: 35075288 Clinical Trial.
Développement des médicaments en pédiatrie : défis existants et recommandations.
Kaguelidou F, Ouèdraogo M, Treluyer JM, Le Jeunne C, Annereau M, Blanc P, Bureau S, Ducassou S, Fiquet B, Flamein F, Gaillard S, Hankard R, Laugel V, Laurent C, Levy C, Marquet T, Polak M, Portefaix A, Vassal G. Kaguelidou F, et al. Therapie. 2023 Jan-Feb;78(1):95-104. doi: 10.1016/j.therap.2022.12.002. Epub 2022 Dec 5. Therapie. 2023. PMID: 36543724 French. No abstract available.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Reply.
Bouazza N, Urien S, Tréluyer JM, Touzot F. Bouazza N, et al. J Allergy Clin Immunol. 2016 Aug;138(2):633-4. doi: 10.1016/j.jaci.2016.02.037. Epub 2016 May 20. J Allergy Clin Immunol. 2016. PMID: 27215489 No abstract available.
Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement.
Zannad F, Maugendre P, Audry A; et les participants à la table ronde N°5 de Giens XXIX :; Avril C, Blaise L, Blin O, Burnel P, Falise-Mirat B, Girault D, Giri I, Goehrs JM, Lassale C, Le Meur R, Leurent P, Ratignier-Carbonneil C, Rossignol P, Satonnet E, Simon P, Treluyer L. Zannad F, et al. Therapie. 2014 Jul-Aug;69(4):339-46. doi: 10.2515/therapie/2014042. Therapie. 2014. PMID: 27393227 French. No abstract available.
Methodological Approaches to Evaluate Fetal Drug Exposure.
Bouazza N, Foissac F, Hirt D, Urien S, Benaboud S, Lui G, Treluyer JM. Bouazza N, et al. Curr Pharm Des. 2019;25(5):496-504. doi: 10.2174/1381612825666190319102812. Curr Pharm Des. 2019. PMID: 30892158 Review.
Amiodarone/N-desethylamiodarone population pharmacokinetics in paediatric patients.
Lehnert A, Foissac F, Bouazza N, Urien S, Oualha M, Renolleau S, Barbanti C, Di Marzio A, Bonnet D, Abdalla S, Zheng Y, Treluyer JM. Lehnert A, et al. Br J Clin Pharmacol. 2022 Dec;88(12):5369-5377. doi: 10.1111/bcp.15458. Epub 2022 Jul 29. Br J Clin Pharmacol. 2022. PMID: 35816412 Free article.
416 results